Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Lupus. 2016 Oct 31;26(7):682–689. doi: 10.1177/0961203316672928

Table 2.

Baseline characteristics of hydroxychloroquine (HCQ) or immunosuppressive drug (ISD) initiators with SLE

Database Commercial Insurance Plans Medicaid Insurance
Medication New Users HCQ (n=2,451) ISD (n=2,451) HCQ (n=7,690) ISD (n=7,690)
Age –mean ± SD 45.7 ± 12.1 45.2 ± 12.1 39.2 ± 12.0 39.2 ± 12.4
HPV-associated factors – N (%)
Sexually active 1920 (78.3) 1943 (79.3) 5560 (72.3) 5569 (72.4)
Sexually transmitted disease 150 (6.1) 141 (5.8) 729 (9.5) 743 (9.7)
Alcoholism 9 (0.4) 10 (0.4) 50 (0.7) 29 (0.6)
Substance abuse 20 (0.8) 23 (0.9) 163 (2.1) 162 (2.1)
Smoking 247 (10.1) 265 (10.8) 976 (12.7) 976 (12.7)
Oral contraceptives 225 (9.2) 232 (9.5) 566 (7.4) 588 (7.7)
Non-oral contraceptives 41 (1.7) 39 (1.6) 287 (3.7) 279 (3.6)
Receipt of HPV vaccine 15 (0.6) 15 (0.6) 33 (0.4) 32 (0.4)
Abnormal Papanicolaou test 130 (5.3) 142 (5.8) 409 (5.3) 420 (5.5)
Comorbidities – N (%)
Chronic kidney disease 270 (11.0) 253 (10.3) 1156 (15.0) 1186 (15.4)
Liver disease 169 (6.9) 166 (6.8) 563 (7.3) 542 (7.1)
Diabetes mellitus 270 (11.0) 252 (10.3) 1106 (14.4) 1159 (15.1)
Mean comorbidity score ± SD* 0.8 ± 1.6 0.8 ± 1.5 1.1 ± 1.8 1.1 ± 1.7
Medications
Mean number of prescriptions ± SD 12.2 ± 7.4 12.2 ± 7.0 16.4 ± 9.2 16.5 ± 8.6
Corticosteroid use – N (%) 1006 (41.0) 1004 (41.0) 4252 (55.3) 4171 (54.2)
Preventive Care – N (%)
Mammogram 890 (36.3) 858 (35.0) 1367 (17.8) 1385 (18.0)
Papanicolaou test 1065 (43.5) 1058 (43.2) 2285 (29.7) 2310 (30.0)
HPV DNA ordered 218 (8.9) 215 (8.8) 346 (4.5) 356 (4.5)
Colonoscopy 243 (9.9) 234 (9.6) 453 (5.9) 456 (5.9)
Healthcare utilization- mean ± SD
Outpatient visits 12.5 ± 8.3 12.7 ± 8.9 10.8 ± 9.3 10.9 ± 8.6
Hospitalizations 0.6 ± 2.5 0.6 ± 1.9 0.7 ± 1.4 0.7 ± 1.4
Emergency Department visits 0.7 ± 3.2 0.8 ± 3.4 2.2 ± 3.9 2.1 ± 3.8
*

The range of the comorbidity score is −2 to 26.